Table 5.
Cardiometabolic risk variables pre- and post-intervention.
| Variable | HIIT group (n = 32) |
MIIT group (n = 22) |
CON group (n = 33) |
|||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| MetS z-score | 3.30 ± 3.79 | 1.48 ± 3.10*** | 2.77 ± 3.93 | 1.58 ± 3.85** | 1.79 ± 2.92 | 1.25 ± 2.77 |
| Systolic BP (mmHg) | 144 ± 16 | 133 ± 11*** | 143 ± 14 | 131 ± 11** | 136 ± 15 | 136 ± 12 |
| Diastolic BP (mmHg) | 94 ± 11 | 86 ± 7*** | 90 ± 7 | 85 ± 8* | 86 ± 11 | 86 ± 9 |
| MAB (mmHg) | 110 ± 11 | 102 ± 7*** | 108 ± 8 | 100 ± 8** | 103 ± 11 | 103 ± 9 |
| Glucose (mg/dL) | 101 ± 17 | 101 ± 14 | 106 ± 29 | 109 ± 32 | 100 ± 18 | 97 ± 17 |
| HbA1c (%) | 5.7 ± 0.5 | 5.6 ± 0.3 | 5.8 ± 0.9 | 5.8 ± 0.9 | 5.6 ± 0.7 | 5.5 ± 0.6 |
| Triglycerides (mg/dL) | 137 ± 59 | 133 ± 45 | 151 ± 86 | 143 ± 88 | 151 ± 80 | 128 ± 61 |
| Cholesterol (mg/dL) | 219 ± 33 | 218 ± 37 | 202 ± 41 | 203 ± 37 | 227 ± 47 | 217 ± 37 |
| HDL (mg/dL) | 48 ± 10 | 49 ± 11 | 51 ± 14 | 51 ± 12 | 54 ± 12 | 54 ± 13 |
| LDL (mg/dL) | 148 ± 28 | 147 ± 31 | 129 ± 27 | 131 ± 27 | 146 ± 33 | 142 ± 29 |
| LDL/HDL ratio | 3.2 ± 1.0 | 3.0 ± 0.9 | 2.6 ± 0.7 | 2.7 ± 0.7 | 2.8 ± 0.8 | 2.8 ± 0.7 |
Values are expressed as mean ± SD. HIIT high-intensity interval training group, MIIT moderate-intensity interval training group, CON control group, BP blood pressure, MAB mean arterial blood pressure, HbA1c glycosylated hemoglobin A1c, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol. *(p < 0.05), **(p < 0.01), ***(p < 0.001), significantly different from pre-intervention.